Fibrogenic cell phenotype modifications during remodelling of normal and pathological human liver in cultured slices

Liver International

Volumn 30, Issue 10, 2010, Pages 1529-1540

  Guyot, Christelle ^a,b   Lepreux, Sébastien ^a,c   Combe, Chantal ^a   Sarrazy, Vincent ^d   Billet, Fabrice ^d   Balabaud, Charles ^a   Bioulac Sage, Paulette ^c   Desmoulière, Alexis ^a,d  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c HÔPITAL PELLEGRIN   (France)

^d UNIVERSITÉ DE LIMOGES   (France)

Author keywords

smooth muscle actin; CD 34; Cirrhosis; Fibrosis; Keratin 19; Liver slice; Platelet derived growth factor receptor ; Thy 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; EOSIN; HEMATOXYLIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; THY 1 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CULTURE; LIVER PARENCHYMA; LIVER SLICE; MALE; PHENOTYPE; PROTEIN EXPRESSION; STELLATE CELL;

ACTINS; AGED; ANTIGENS, CD34; ANTIGENS, THY-1; APOPTOSIS; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CHOLESTASIS, INTRAHEPATIC; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; HEPATIC STELLATE CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; KI-67 ANTIGEN; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MYOFIBROBLASTS; PHENOTYPE; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TIME FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 79951632495     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02342.x     Document Type: Article

References (27)

1. Friedman SL, Bansal MB. Reversal of hepatic fibrosis - fact or fantasy? Hepatology 2006; 43(Suppl. 1): S82-8.
2. Pol S, Carnot F, Nalpas B, et al. Reversibility of hepatitis C virus-related cirrhosis. Human Pathol 2004; 35: 107-12.
3. Hammel P, Couvelard A, O'Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001; 344: 418-23.
4. Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004; 40: 860-7.
5. Guyot C, Lepreux S, Combe C, et al. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006; 38: 135-51.
6. Vickers AE, Saulnier M, Cruz E, et al. Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis. Toxicol Sci 2004; 82: 534-44.
7. Van de Bovenkamp M, Groothuis GM, Draaisma AL, et al. Precision-cut liver slices as a new model to study toxicityinduced HSC activation in a physiologic milieu. Toxicol Sci 2005; 85: 632-8.
8. Olinga P, Groen K, Hof IH, et al. Comparison of five incubation systems for rat liver slices using functional and viability parameters. J Pharmacol Toxicol Methods 1997; 38: 59-69.
9. Olinga P, Merema MT, de Jager MH, et al. Rat liver slices as a tool to study LPS-induced inflammatory response in the liver. J Hepatol 2001; 35: 187-94.
10. Clouzeau-Girard H, Guyot C, Combe C, et al. Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab Invest 2006; 86: 275-85.
11. Guyot C, Combe C, Balabaud C, Bioulac-Sage P, Desmoulière A. Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices. J Hepatol 2007; 46: 142-50.
12. Van de Bovenkamp M, Groothuis GMM, Meijer DKF, Olinga P. Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro. J Hepatol 2006; 45: 696-703.
13. Skalli O, Ropraz P, Trzeciak A, et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103: 2787-96.
14. Dudas J, Tümen Mansuroglu T, Batusic D, Ramadori G. Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury. Histochem Cell Biol 2009; 131: 115-27.
15. Pinzani M, Milani S, Herbst H, et al. Expression of plateletderived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996; 148: 785-800.
16. Couvelard A, Scoazec JY, Feldmann G. Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver. Am J Pathol 1993; 143: 738-52.
17. LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte proliferation. Liver 2001; 21: 73-80.
18. Costa AM, Tuchweber B, Lamireau T, et al. Role of apoptosis in the remodeling of cholestatic liver injury following release of the mechanical stress. Virchows Arch 2003; 442: 372-80.
19. Saile B, Matthes N, Neubauer K, et al. Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2002; 283: G435-44.
20. Desmoulière A. Hepatic stellate cells: the only cells involved in liver fibrogenesis? A dogma challenged. Gastroenterology 2007; 132: 2059-62.
21. Dranoff JA, Wells RG. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 2010; 51: 1438-44.
22. Peyton SR, Ghajar CM, Khatiwala CB, Putnam AJ. The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function. Cell Biochem Biophys 2007; 47: 300-20.
23. Verrill C, Davies J, Millward-Sadler H, Sundstrom L, Sheron N. Organotypic liver culture in a fluid-air interface using slices of neonatal rat and adult human tissue - a model of fibrosis in vitro. J Pharmacol Toxicol Methods 2002; 48: 103-10.
24. Tuchweber B, Desmoulière A, Bochaton-Piallat ML, Rubbia-Brandt L, Gabbiani G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 1996; 74: 265-78.
25. Bosselut N, Housset C, Marcelo P, et al. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 2010; 10: 1017-28.
26. Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000; 124: 1599-607.
27. Van de Bovenkamp M, Groothuis GMM, Meijer DKF, Olinga P. Liver fibrosis in vitro: cell culture models and precision-cut liver slices. Toxicol In Vitro 2007; 21: 545-57.